NovoArc GmbH
PrivateLast Round
Seed
Dec 9, 2024
Total Funding Raised
$1.2M
Company Overview
NovoArc GmbH is a biotechnology company that develops and manufactures lipid-based formulations to enable the oral delivery of drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NovoArc GmbH Comps
Public and private peers based on sector, stage, and business model.
NovoArc GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 9, 2024 | ||||
| Seed | Feb 1, 2022 |
NovoArc GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Austria Wirtschaftsservice | Grant, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 9, 2024
$960K round led by Austria Wirtschaftsservice
- Feb 1, 2022
Completed a Seed funding round.
NovoArc GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NovoArc GmbH's valuation, stock price, and market status.
